The objective of this study is to obtain data on the efficacy of the Vielight RX Plus in decreasing time to recovery of symptoms in subjects with COVID-19. The study will be conducted among COVID-19 positive subjects at home in self-isolation via electronic data collection (EDC). There will be no physical contact between the subjects and the Investigators or other study staff. This study aims to demonstrate that the Vielight RX Plus is a useful adjunct to standard of care (SOC). We hypothesize that the Vielight RX Plus will accelerate recovery and reduce viral infection severity.

A Randomized Study Evaluating the Efficacy of the Vielight RX Plus in the Treatment of COVID-19 Respiratory Symptoms

Vielight Inc., Patient Recruitment, USA, Province of Ontario

Eligibility Criteria

All genders

18 to 65 years old

Have a positive test report for COVID-19.

Have no chronic immune or lung condition.

Are not currently pregnant.

At home in self-isolation.

Study Tasks

Daily questionnaires

Ethics

Keywords

Activity and Time

Health and Wellness

Clinical Trial

Weekdays

30 days total, 30 sessions

All participants will have to complete daily online questionnaires.

Compensation

$150

Study Address

This study doesn't require any in-person visits. Complete it in the comfort of your own home!